LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
作者:
关键词
Apoptosisbone marrow cellsbone marrow transplantationcell therapycolony-stimulating factorsfree radicalsheart failureinflammation/prevention & controlinfusions, intra-arterialmagnetic resonance imagingmyocardial infarction/therapymyocardial ischemia/therapymyocardial reperfusion injurymyocytes, cardiacprospective studiesregenerationresearch designstem cell transplantationstem cellstime factorsventricular function, leftventricular remodeling
主题词
血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);骨髓移植(Bone Marrow Transplantation);双盲法(Double-Blind Method);超声心动描记术(Echocardiography);心力衰竭(Heart Failure);人类(Humans);磁共振成像(Magnetic Resonance Imaging);心肌梗死(Myocardial Infarction);心肌(Myocardium);试点项目(Pilot Projects);安慰治疗效应(Placebo Effect);研究设计(Research Design);时间因素(Time Factors);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome);美国(United States);心室功能, 左(Ventricular Function, Left);心室重构(Ventricular Remodeling)
PMID
20844613
发布时间
2022-03-10
- 浏览130
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文